European Antibody Congress 2016

The European Antibody Congress is where pharma, biotechs, clinicians, researchers & innovative start-ups gather to develop new strategies and partnerships to advance antibody drug discovery, development, and commercialisation. Join the largest antibody event focused on getting important new therapeutics and immunotherapies into the clinic and see where antibody development is headed next. The European Antibody Congress 2016 will introduce a innovation zone to provide opportunities for the SMEs to get in front of key pharma, biotech and investors from the Antibody industry. 2016 will also see an increased focus on Immunotherpy as we look to welcome over 500 attendees to the European Antibody Congress 2016 and the co-located World Biosimilar Congress 2016, World Immunotherapy Congress 2016 and HPAPI World Congress 2016.